S095024 is a humanized IgG1 monoclonal antibody inhibitor targeting CD73. It is applicable in research related to acute respiratory distress syndrome (ARDS), non-small cell lung cancer (NSCLC), and advanced solid tumors [malignant neoplasms].
Target:
CD73
* VAT and and shipping costs not included. Errors and price changes excepted
